Angene Chemical
Draw
|
Currency :
Home Products

AG00DAAN

54276-17-4 | Travoprost Acid

Chemical structure of Travoprost Acid, CAS 54276-17-4
AG00DAAN
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 54276-17-4
Catalog Number AG00DAAN(AGN-PC-0SGWBR)
Chemical Name Travoprost Acid
EC Number 255-029-3
IUPAC Name (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoic acid
InChI InChI=1S/C23H29F3O6/c24-23(25,26)15-6-5-7-17(12-15)32-14-16(27)10-11-19-18(20(28)13-21(19)29)8-3-1-2-4-9-22(30)31/h1,3,5-7,10-12,16,18-21,27-29H,2,4,8-9,13-14H2,(H,30,31)/b3-1-,11-10+/t16-,18-,19-,20+,21-/m1/s1
InChI Key WWSWYXNVCBLWNZ-QIZQQNKQSA-N
MDL Number MFCD00210955
Molecular Formula C23H29F3O6
Molecular Weight 458.4680
SMILES O=C(O)CCC/C=CC[C@@H]1[C@@H](/C=C/[C@@H](O)COC2=CC=CC(C(F)(F)F)=C2)[C@H](O)C[C@@H]1O
UNII MEH3MCE8X1
Synonyms
fluprostenol, fluprostenol monosodium salt, fluprostenol, ((1alpha(Z),2beta(1E,3R*),3alpha,5alpha)-(+-))-isomer, fluprostenol, ((1R-(1alpha(Z),2beta(1E,3R*),3alpha,5alpha))-(+-))-isomer, ICI 81,008, fluprostenol, travoprost acid, (+)-fluprostenol, Fluprostenolum, 54276-17-4, travoprost free acid, ICI 81,008, UNII-MEH3MCE8X1, 40666-16-8, EINECS 255-029-3, CHEBI:60782, MEH3MCE8X1, NCGC00160386-01, Fluprostenol [INN:BAN], ICI 81008, Fluprostenolum [INN-Latin], AL-5848, (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoic acid, rac-(5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-{(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-en-1-yl}cyclopentyl]hept-5-enoic acid, Fluprostenol, (+)-, [3H](+)-fluprostenol, [3H]-(+)-fluprostenol, Travoprost related compound A A, Travoprost related compound A [USP], AC1NSJZQ, Travoprost related compound A RS [USP], DSSTox_CID_26122, DSSTox_RID_81358, DSSTox_GSID_46122, BSPBio_001336, SCHEMBL230607, BML2-G08, GTPL1940, GTPL3417, CHEMBL1201379, DTXSID7046122, WWSWYXNVCBLWNZ-QIZQQNKQSA-N, Fluprostenol 10 mg/mL in ethanol, HMS1361C18, HMS1791C18, HMS1989C18, HMS3402C18, HMS3648H08, ZINC4474587, Tox21_111778, 1007AH, 1771AH, BDBM50206025, MFCD03427566, 16-(m-Trifluoromethylphenoxy)-17,18,19,20-tetranorprostaglandin F2alpha, AKOS024458212, AL 5848, IDI1_033806, NCGC00160386-02, NCGC00160386-04, NCGC00160386-05, (5Z ,13E )-(9S,11R,15R )-9,11,15-Trihydroxy-16-(m-trifluoromethylphenoxy)-17,18,19,20-tetranor-5,13-prostadienoic acid, 5-Heptenoic acid, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3R)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)-1-buten-1-yl)cyclopentyl)-, (5Z)-, CAS-40666-16-8, 276F174, SR-01000946504, SR-01000946504-1, BRD-K31611373-001-02-7, UNII-358S7VUE5N component WWSWYXNVCBLWNZ-QIZQQNKQSA-N, (+/-)-16-(3-Trifluoromethylphenoxy)tetranorprostaglandin F2alpha, 16-(m-Trifluoromethylphenoxy)-17,18,19,20-tetranorprostaglandin F2|A, (5Z)-7-((1R,2R,3R,5S)-2-((R,E)-4-(3-(trifluoromethyl)phenoxy)-3-hydroxybut-1-enyl)-3,5-dihydroxycyclopentyl)hept-5-enoic acid, (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]cyclopentyl]-5-heptenoic acid, (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic Acid, (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-en-1-yl]cyclopentyl]hept-5-enoic acid, (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoic acid, (Z)-7-[(1alpha)-3alpha,5alpha-Dihydroxy-2beta-[(3R,1E)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic acid, [1R-[1|A(Z),2|A(1E,3R*),3|A,5|A]]-7-[3,5-Dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic Acid, UNII-358S7VUE5N, D05TNX, D08TWE, fluprostenol monosodium salt, 358S7VUE5N, C23H29F3O6, C23-H29-F3-O6, CID5311100, C006326, fluprostenol, ((1alpha(Z),2beta(1E,3R*),3alpha,5alpha)-(+-))-isomer, fluprostenol, ((1R-(1alpha(Z),2beta(1E,3R*),3alpha,5alpha))-(+-))-isomer, 5-Heptenoic acid, 7-[3,5-dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-, [1.alpha.(Z),2.beta.(1E,3R*),3.alpha.,5.alpha.]-(.+-.)-, 5-Heptenoic acid, 7-[3,5-dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-, [1.alpha.(Z),2.beta.(1E,3R*),3.alpha.,5.alpha.]-(.+.)-,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited